BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25237123)

  • 1. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.
    Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K
    J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsive choice and response in dopamine agonist-related impulse control behaviors.
    Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M
    Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in impulse control behaviours of Parkinson's disease.
    Zurowski M; O'Brien JD
    Curr Opin Neurol; 2015 Aug; 28(4):387-92. PubMed ID: 26110803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
    Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
    Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic influences on risk preferences of Parkinson's disease patients.
    Kobayashi S; Asano K; Matsuda N; Ugawa Y
    Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.
    Bellosta Diago E; Lopez Del Val LJ; Santos Lasaosa S; López Garcia E; Viloria Alebesque A
    Neurologia; 2017 Oct; 32(8):494-499. PubMed ID: 27087472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
    Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
    Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
    Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Tomassini A; Foltynie T; Limousin P; Aviles-Olmos I; Warner TT; Lees AJ; Averbeck BB
    J Parkinsons Dis; 2014; 4(4):579-83. PubMed ID: 25061059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease.
    Choi JH; Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho JW
    Neurodegener Dis; 2019; 19(5-6):171-177. PubMed ID: 32454490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.
    Castrioto A; Funkiewiez A; Debû B; Cools R; Lhommée E; Ardouin C; Fraix V; Chabardès S; Robbins TW; Pollak P; Krack P
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):186-90. PubMed ID: 24860137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.